1BD.F BIO-WORKS TECHN. AB

Healthcare Biotechnology Frankfurt Exchange
0.2520 EUR
Close of Nov 11, 2026
0.1800 0.4140
Market cap
EUR 25.3M
P/E
-
P/B
6.24x
ROE
-16.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 1BD.F undervalued?

Graham number

The Graham number of BIO-WORKS TECHN. AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BIO-WORKS TECHN. AB fundamental analysis

No fundamental analysis for BIO-WORKS TECHN. AB yet.

BIO-WORKS TECHN. AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BIO-WORKS TECHN. AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD forma…

Full company profile